GIOSTAR Chicago

Regenerative Medicine Center of Orthopedics and Other Degenerative Diseases located in Glenview, IL

For Immediate Release


Global Institute of Stem Cell Therapy and Research (GIOSTAR)
Opens New Location in Glenview, Illinois
September 7, 2018

Learn More

GIOSTAR CHICAGO

GIOSTAR CHICAGO is supported by Global Institute of Stem Cell Therapy and Research (GIOSTAR), who is the pioneer in regenerative medicine and stem cell-based technologies. For over 10 years, the institute has treated degenerative diseases through innovative applications of regenerative medicine. Headquartered in San Diego, California, the institute is an established leader in what is widely regarded as the most highly advanced field of science.

GIOSTAR is comprised of world-renowned international group of researchers, doctors and scientists in the field of stem cell biology, cancer, and gene therapy. The team has won numerous awards, conducted pioneering clinical studies, and published extensive research in leading medical journals. Further, GIOSTAR has helped develop the stem cell research programs for prestigious institutions in the U.S.A., such as the University of California San Diego (UCSD), Salk Research Institute, San Diego, California, University of California Irvine (UCI), Burnham Institute of Medical Research, San Diego, California and University of California Los Angeles (UCLA).

GIOSTAR is the leader in developing the most advanced stem cell-based technologies, supported by prominent scientists and physicians trained at Harvard, Stanford, and other leading universities. As a leader in the field of regenerative medicine, GIOSTAR’s vision is to provide cost-effective, safe, customized, and extensively researched stem cell-based therapies to those suffering from degenerative or genetic diseases.

About Our Practice

 

Patients at GIOSTAR Chicago in Glenview, Illinois, benefit from and can depend on safe, extensively researched regenerative cell-based therapies designed to rejuvenate and treat several musculoskeletal injuries and degenerative conditions. 

GIOSTAR Chicago offers cutting-edge regenerative medicine techniques and protocols that have been extensively researched and developed by our leading scientists. Our team consists of world-renowned authorities in stem cell biology, protein biochemistry, molecular biology, immunology, in utero transplantation of stem cell, tissue targeting, gene therapy and clinical research. GIOSTAR Chicago also offers patients cutting-edge clinical treatments from our leading physicians.

The regenerative cells that also contain stem cells are the "mother cells," and are responsible for developing the entire human body due to their unlimited division and strong power to differentiate into different cell lineage. This power of regenerative cells has been harnessed by the technology to isolate them outside the human body, pass through stringent quality and quantity checks, and implant them into the body to regenerate degenerating organs.

Thus, regenerative cell treatment involves administration of concentrated cells in the targeted area, wherein they may colonize in the damaged area, and initiate some of the lost functions that have been compromised by the disease or injury.

The regenerative cells that also contain mesenchymal stem cells are known to have angiogenic, transdifferentiation and homing properties, which are useful for forming new blood vessels, differentiating into required targeted cells and creation of microenvironment for the faster secretion of immune cells. 

If you suffer from a degenerative condition and have lost hope for recovery, you are not alone. Regenerative cell therapy at GIOSTAR Chicago may help you. However, we do not take each and every patient that is interested in this type of therapy. We base our decision on several factors including (but not limited to), the progression and severity of the condition, a patient's age, their medical history, and other stringent inclusion and exclusion criteria. Screening involves a 3-step process to determine whether or not you are a candidate. If you are interested in applying for potential candidacy, please fill out this confidential, medical review form.

Read more
GIOSTAR Chicago

 

Patients at GIOSTAR Chicago in Glenview, Illinois, benefit from and can depend on safe, extensively researched regenerative cell-based therapies designed to rejuvenate and treat several musculoskeletal injuries and degenerative conditions. 

GIOSTAR Chicago offers cutting-edge regenerative medicine techniques and protocols that have been extensively researched and developed by our leading scientists. Our team consists of world-renowned authorities in stem cell biology, protein biochemistry, molecular biology, immunology, in utero transplantation of stem cell, tissue targeting, gene therapy and clinical research. GIOSTAR Chicago also offers patients cutting-edge clinical treatments from our leading physicians.

The regenerative cells that also contain stem cells are the "mother cells," and are responsible for developing the entire human body due to their unlimited division and strong power to differentiate into different cell lineage. This power of regenerative cells has been harnessed by the technology to isolate them outside the human body, pass through stringent quality and quantity checks, and implant them into the body to regenerate degenerating organs.

Thus, regenerative cell treatment involves administration of concentrated cells in the targeted area, wherein they may colonize in the damaged area, and initiate some of the lost functions that have been compromised by the disease or injury.

The regenerative cells that also contain mesenchymal stem cells are known to have angiogenic, transdifferentiation and homing properties, which are useful for forming new blood vessels, differentiating into required targeted cells and creation of microenvironment for the faster secretion of immune cells. 

If you suffer from a degenerative condition and have lost hope for recovery, you are not alone. Regenerative cell therapy at GIOSTAR Chicago may help you. However, we do not take each and every patient that is interested in this type of therapy. We base our decision on several factors including (but not limited to), the progression and severity of the condition, a patient's age, their medical history, and other stringent inclusion and exclusion criteria. Screening involves a 3-step process to determine whether or not you are a candidate. If you are interested in applying for potential candidacy, please fill out this confidential, medical review form.


Read less

How do we stand out from local area centers?


GIOSTAR CHICAGO leverages GIOSTAR's customized, proprietary treatment protocols to treat each and every one of our patients. Our protocols were developed based on research grants, endowment, and private funding. Regenerative medicine is a highly complex field of medicine that requires years and years of extensive ongoing research. Most local centers do not fully grasp the nuances and intricacies of this field. They do not have teams of dedicated research scientists conducting ongoing US-based clinical studies to enable their centers to continue providing the most advanced science to their patients.

We do.

The GIOSTAR Chicago center does not take a “one size fits all” approach to medicine. GIOSTAR was formed a decade ago to do intensive research, and strives for higher quality control and excellence. Our scientists hail from University of California, San Diego (UCSD), Salk Institute, University of California Irvine (UCI), University of California Los Angeles (UCLA), and other prestigious USA universities. Armed with extensive training, they deliver cutting edge, research-based treatment protocols to GIOSTAR Chicago and beyond. This rigorous approach enables us to stay abreast of the latest techniques and advancements in the ever-evolving field of regenerative medicine. In parallel with patient care, our teams of highly-skilled research scientists devote countless hours each day to make history by advancing the field of medicine and changing people’s lives for the better.

 

Dr. Anand Srivastava is a proud recipient of the United States House of Representatives Certificate of Recognition for "Best Of Business" in recognition for co-founding GlOSTAR

Dr. Anand Srivastava cloned 27 genes while working for the government of Japan in 1998. In 1997 and 1998, he was awarded the Japan International Science and Technology Exchange Center (JISTEC) Award, a highly prestigious international scientific award. He is the only recipient to have earned this accolade twice. Dr. Srivastava also made the Who’s Who award in 2005, 2010, 2014, and 2018.

Working at UC Irvine, Dr. Srivastava and the team of researchers conducted the first FDA Approved Human Clinical Trial with the Christopher & Dana Reeve Foundation for spinal cord injury in 2007.

You now have direct access to a higher level of expertise for your stem cell therapy.

Learn More About Dr. Srivastava

Read more

 


Working at UC Irvine, Dr. Srivastava and the team of researchers conducted the FIRST FDA Approved Human Clinical Trial with the Christopher & Dana Reeve Foundation for spinal cord injury in 2007.

You now have direct access to a higher level of expertise for your stem cell therapy.


Read more

"We live in a time when the words 'impossible' and 'unsolvable' are no longer part of the scientific community's vocabulary. Each day we move closer to trials that will not just minimize the symptoms of disease and injury but eliminate them.”

– Christopher Reeve, founder of the Christopher & Dana Reeve Foundation and supporter of stem cell research

GIOSTAR on ABC 10 News USA

14,000+

Treatments have been completed worldwide

92

Articles have been published in medical journals by the medical board

20

Years experience in providing clinical treatments

7

Locations offering stem cell treatments throughout the world

Prior to his passing in 2018, renowned physicist Stephen Hawking met with Mr. Deven Patel, CEO of GIOSTAR, to learn about how stem cell research could help treat Amyotrophic Lateral Sclerosis (ALS), the neurological disease he'd suffered from for most of his life.

Click below to read more!

Read More

Read more

THE SAFEST AND MOST EFFECTIVE STEM CELL THERAPY IN 7 COUNTRIES

GIOSTAR OFFERS YOU ACCESS TO GOVERNMENT AND UNIVERSITY LEVEL RESEARCH THAT BEGAN IN 1998

SCIENTIFIC CONTRIBUTIONS

Dr. Anand is credited with many of the fundamental creations that have made the entire industry of modern stem cell science possible. Governments worldwide rely on his expertise and guidance to determine policy, best practices and safety procedures.

AWARDS & RECOGNITION

Dr. Anand and GIOSTAR have been recognized by several governments worldwide, Japan, India, Poland, Saudi Arabia, and Mexico, for our work. Further, the team has received the prestigious Best In Business award by the United States Government for research and service for treatment of debilitating diseases.

PUBLICATIONS & JOURNALS

Dr. Anand’s discoveries, innovations and publications are the most utilized by doctors and scientists in the field of stem cells. There are many journals dedicated to his work, he is a world renowned speaker and is the reviewer of several journals in the industry.

FDA TRIALS

While working at UC Irvine, Dr. Anand and the team of researchers conducted the FIRST FDA Approved Human Clinical Trial with Christopher and Dana Reeves Foundation for spinal cord injury in 2007. You now have direct access to this level of expertise for your stem cell therapy.
 

Orthopedic treatments available  for the following conditions


 Knee/Shin Pain Shoulder Pain Hip Pain Ankle/Foot Pain Hand/Wrist Pain Elbow Pain

Learn More

Avoid the scams.

What patients should watch out for when selecting their treatment providers

Learn More

To learn more about how GIOSTAR is changing lives, read the Facebook reviews!




GIOSTAR CEO, Mr. Deven Patel succeeded in bringing his vision: “to deliver the most advanced and expensive science to the most impoverished masses of India” to fruition. It is with this advancement, that GIOSTAR is changing the face of regenerative medicine today around the globe.


Read more
Testimonials

Words from our patients

  • facebook

    "At last I decided to do this treatment. Now I feel that it was totally worth it. My body is very flexible. I can move very comfortably."

    Jack G.
  • facebook

    "I kept hope and faith in this and it helped me to overcome this situation. The best part of it is now I do not take insulin doses and medicines any more."

    Yash K.
  • facebook

    "Thanks seems like a very small word to express my gratitude for what GIOSTAR and its team of doctors have done for me."

    Rajat G.
  • facebook

    "After I was done with the treatment, my condition is a lot better now. I don’t have pain in my knees and can walk with ease."

    Samita G.
  • facebook

    "GIOSTAR came like a ray of hope into my life and made myself free from the pain I had in the abdomen. Now, I don’t feel tired rather I feel very much energetic."

    John H.
  • facebook

    "I hope that many others like me benefit from Diabetes Treatment using stem cells.”

    Harish P.
  • facebook

    "My recent reports are also showing signs of improvement, and my hopes are really high."

    Peter W.

DISCLAIMER: Anyone who accesses this web site, before following any of the guidance or making any decisions or reaching any conclusions from the web site should first consult their own physician.
Regenerative medicine has been called the “next evolution of medical treatments,” by the U.S. Department of Health and Human Services. “With its potential to heal, this new field of science is expected to revolutionize health care.”

All stem cell research carried out by GIOSTAR researchers and scientists has followed strict scientific and ethical guidelines directed by National Institute of Health, USA and approved by National Institute of health, USA. All publications/research in the field of stem cell is done at the most prestigious Universities of USA and are peer reviewed and available at “PubMed” a web page managed by National Institute of health, USA.

GIOSTAR also works in accordance with the guidelines of International Society of Stem Cell Research (ISSCR) and International Society for Cellular Therapy (ISCT).

Our stem cell therapy procedures are in accordance with FDA regulations CFR21 Part 1271 (1271.15.b). Stem cell transplants or bone marrow transplants are regular clinical practice in United States and many other countries for more than 25 years. Stem cell transplants or Bone marrow transplants are being used to treat patients with hematological disorders such as sickle cell anemia, thalassemia, leukemia and lymphomas etc.

GIOSTAR also follows the ethical guidelines in accordance with the World Medical Association’s WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects — “In the treatment of a patient, where proven interventions do not exist or have been ineffective, the physician, may use an unproven intervention if in the physician’s judgment it offers hope of saving life, re-establishing health or alleviating suffering.”

Any and all opinions and/or statements offered on this website are for the information and education purpose only. GIOSTAR and its affiliate centers are offering certain investigational treatments using adipose / bone marrow which uses patients own cells which is called autologous transplant. The centers only provide surgical procedures and centers are not involved in the use or manufacture of any investigational drugs.

Other than hematological disorders, this website does not claim that any applications using cells offer to cure, treat or prevent any medical condition and it is not evaluated or approved by USA FDA. This website does not offer any medical advice. It is critically important for any patient to do his or her own research to reach an informed decision. It is completely voluntary decision by any and all patients to participate in some of our patient funded clinical studies at various locations around the world.

The testimonials, statements, and opinions presented on this website are applicable to the individuals depicted. Results may vary and may not be representative of the experience of others. The testimonials are representative of patient experience but the exact results and experience will be unique and individual to each patient.

Moreover, each country has its own country specific stem cell regulations depending on its need. For India, GIOSTAR follows guidelines set up by Government of India. Furthermore, GIOSTAR is working with Government of India and developing stem cell research and transplant program for the large populous of millions in India suffering from genetic and hematological diseases.

Creating positive and significant impact for human race is our primary goal. From research to treatment is our purpose.